Stem Cells Treatment for Wilson Disease.

Area of Science:

• Hepatology
• Genetics
• Regenerative Medicine

Background:

• Wilson Disease (WD) is a genetic disorder characterized by impaired copper excretion, primarily due to ATP7B gene mutations.
• Current treatments, including pharmacotherapy and liver transplantation, have limitations such as poor patient compliance, adverse drug reactions, and a scarcity of donor organs.

Purpose of the Study:

• To review the latest advancements in stem cell therapy for Wilson Disease.
• To discuss the potential of stem cells to permanently correct copper metabolism abnormalities in WD.
• To outline the current challenges and future prospects of stem cell-based treatments for WD.

Main Methods:

• Literature review of recent studies on stem cell applications in Wilson Disease models and clinical research.
• Analysis of different stem cell types and their mechanisms of action in copper metabolism regulation.
• Evaluation of challenges including cell engraftment, differentiation, and safety.

Main Results:

• Stem cell therapy demonstrates potential for restoring normal copper excretion and ameliorating WD pathology.
• Various stem cell sources, including mesenchymal stem cells and induced pluripotent stem cells, are being investigated.
• Preclinical studies show promising results in animal models of Wilson Disease.

Conclusions:

• Stem cell therapy represents a promising and potentially curative approach for Wilson Disease, offering an alternative to conventional treatments.
• Further research is needed to overcome challenges related to efficacy, safety, and standardization of stem cell therapies for WD.
• The future of Wilson Disease treatment may involve regenerative medicine strategies for long-term disease management.